Blood products for bdaach, 04-02-2024 - 06-30-2024
Ended Awarded Last action
- Contract number
- W81K0224F0044
- Awardee
-
The Republic Of Korea National Red Cross UEI PWQUAWD9VUF3
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $8,528
Award facts
- Contract value 100% obligated
- $8,527.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- South Korea
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $8,528 | |
| Original award | $0 |
About this award
This federal contract award was issued by the Defense Health Agency (DHA) to the Republic of Korea National Red Cross, doing business as the Gyeonggi Blood Center Red Cross, an international non-profit organization. The $8,527.99 firm-fixed-price contract is for the provision of blood products, including apheresis platelets and whole blood units, to support U.S. military medical facilities in South Korea. The contract is structured as a Blanket Purchase Agreement (BPA) call, with a performance period from April 2, 2024 to June 30, 2024. The Gyeonggi Blood Center Red Cross operates its own facilities in South Korea and performs all work under this contract. This award is not associated with any set-aside designation. The Gyeonggi Blood Center Red Cross also holds a larger $249,000 single-award BPA with the DHA, with an ultimate completion date of June 30, 2027, which streamlines the procurement of essential blood products for the U.S. military healthcare operations in the region.
Quick answers
Who was awarded contract W81K0224F0044?
W81K0224F0044 was awarded to The Republic Of Korea National Red Cross by Medical Command (Department of the Army) on April 1, 2024.
How much is contract W81K0224F0044 worth?
The government has obligated $8,528 on W81K0224F0044.
Which agency awarded contract W81K0224F0044?
Medical Command (Department of the Army) awarded W81K0224F0044, with funding from Defense Health Agency (Department of Defense).
Is contract W81K0224F0044 an order under another contract?
Yes. W81K0224F0044 is a BPA call under W81K0222A0009, a blanket purchase agreement.
Was contract W81K0224F0044 competed?
The extent of competition for W81K0224F0044 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award